Is Microbix Biosystems (TSE:MBX) A Risky Investment?
Aug 15
Have your own idea? Try our Stock Screener
Canadian (TSX) Biotech Industry Analysis
UpdatedAug 25, 2025
DataAggregated Company Financials
Companies26
- 7D-0.3%
- 3M5.5%
- 1Y12.0%
- YTD-11.7%
The Biotech is pretty flat in the last 7 days, but Spectral Medical has stood out, gaining 26%. As for the the longer term, the industry is up 12% over the past 12 months. Looking forward, earnings are forecast to decline by 4.3% per year.
Industry Valuation and Performance
Has the Canadian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 Aug 2025 | CA$1.7b | CA$90.9m | -CA$233,218,078.54 | 27.7x | -7.2x | 18.4x |
| Wed, 23 Jul 2025 | CA$1.5b | CA$91.0m | -CA$270,292,991.36 | 23.1x | -5.5x | 16.5x |
| Fri, 20 Jun 2025 | CA$1.5b | CA$90.6m | -CA$286,271,943.86 | 23x | -5.3x | 16.6x |
| Sun, 18 May 2025 | CA$1.5b | CA$91.9m | -CA$294,144,651.55 | 23.4x | -5.2x | 16.6x |
| Tue, 15 Apr 2025 | CA$1.4b | CA$92.1m | -CA$285,802,006.56 | 20.1x | -4.7x | 14.7x |
| Thu, 13 Mar 2025 | CA$1.5b | CA$88.6m | -CA$321,973,718.75 | 20.1x | -4.7x | 17.1x |
| Sat, 08 Feb 2025 | CA$1.6b | CA$87.5m | -CA$318,672,065.64 | 25.4x | -5.1x | 18.7x |
| Mon, 06 Jan 2025 | CA$1.5b | CA$85.6m | -CA$323,047,160.89 | 16x | -4.7x | 17.6x |
| Wed, 04 Dec 2024 | CA$1.5b | CA$83.4m | -CA$310,777,846.98 | 8.8x | -5x | 18.5x |
| Fri, 01 Nov 2024 | CA$1.4b | CA$80.4m | -CA$282,330,140.34 | 8.4x | -4.9x | 17.3x |
| Sun, 29 Sep 2024 | CA$978.9m | CA$80.2m | -CA$277,591,819.82 | 8.9x | -3.5x | 12.2x |
| Tue, 27 Aug 2024 | CA$978.6m | CA$80.2m | -CA$283,841,817.27 | 9.5x | -3.4x | 12.2x |
| Thu, 25 Jul 2024 | CA$1.1b | CA$76.2m | -CA$340,662,956.19 | 10.9x | -3.3x | 14.6x |
| Sat, 22 Jun 2024 | CA$1.1b | CA$76.8m | -CA$339,844,972.86 | 11.3x | -3.2x | 14.4x |
| Mon, 20 May 2024 | CA$1.1b | CA$77.1m | -CA$367,553,411.37 | 11.1x | -3.1x | 14.7x |
| Wed, 17 Apr 2024 | CA$907.1m | CA$79.5m | -CA$302,235,958.23 | 12.9x | -3x | 11.4x |
| Fri, 15 Mar 2024 | CA$1.1b | CA$91.6m | -CA$320,148,221.50 | 10.8x | -3.4x | 12x |
| Sun, 11 Feb 2024 | CA$1.1b | CA$87.2m | -CA$323,611,413.38 | 9.9x | -3.3x | 12.1x |
| Tue, 09 Jan 2024 | CA$3.6b | CA$86.2m | -CA$515,782,836.00 | 6.7x | -7x | 42x |
| Thu, 07 Dec 2023 | CA$3.8b | CA$86.1m | -CA$543,184,326.00 | 5.6x | -6.9x | 43.6x |
| Sat, 04 Nov 2023 | CA$3.8b | CA$88.9m | -CA$536,719,252.00 | 7.8x | -7x | 42.3x |
| Mon, 02 Oct 2023 | CA$3.9b | CA$88.9m | -CA$530,974,924.00 | 6x | -7.3x | 43.8x |
| Wed, 30 Aug 2023 | CA$4.0b | CA$87.4m | -CA$507,524,320.00 | 5.7x | -7.8x | 45.3x |
| Fri, 28 Jul 2023 | CA$4.0b | CA$81.5m | -CA$516,441,161.00 | 13.9x | -7.8x | 49.5x |
| Sun, 25 Jun 2023 | CA$4.0b | CA$86.4m | -CA$547,260,560.00 | 13x | -7.4x | 46.8x |
| Tue, 23 May 2023 | CA$3.8b | CA$82.8m | -CA$608,966,275.00 | 11.4x | -6.3x | 46.2x |
| Thu, 20 Apr 2023 | CA$3.7b | CA$83.8m | -CA$596,817,142.00 | 12.9x | -6.2x | 43.9x |
| Sat, 18 Mar 2023 | CA$2.6b | CA$90.6m | -CA$599,816,410.00 | 7.7x | -4.3x | 28.8x |
| Mon, 13 Feb 2023 | CA$3.0b | CA$89.0m | -CA$587,678,953.00 | 8.4x | -5.1x | 33.5x |
| Wed, 11 Jan 2023 | CA$2.9b | CA$87.5m | -CA$525,884,439.00 | 11.7x | -5.5x | 33x |
| Fri, 09 Dec 2022 | CA$3.3b | CA$88.6m | -CA$578,916,669.00 | 7.1x | -5.7x | 37x |
| Sun, 06 Nov 2022 | CA$3.1b | CA$87.7m | -CA$570,364,759.00 | 13x | -5.4x | 34.9x |
| Tue, 04 Oct 2022 | CA$3.3b | CA$86.1m | -CA$548,778,419.00 | 13.5x | -6x | 38.3x |
| Thu, 01 Sep 2022 | CA$3.5b | CA$84.6m | -CA$536,441,804.00 | 13.9x | -6.6x | 41.9x |
Price to Earnings Ratio
-6.6x
Current Industry PE
- Investors are pessimistic on the Canadian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 27.4x is higher than the industry's current PS ratio of 18.4x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 2.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare industry?
| CA Market | 1.64% | |
| Healthcare | 1.84% | |
| Biotech | -0.34% | |
| Biotech | -0.34% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| EDT Spectral Medical | CA$1.40 | 26.1% +CA$82.9m | 102.9% | PS158x | |
| GLAB Gemina Laboratories | CA$0.60 | 20.0% +CA$7.7m | 33.3% | PS4223.4x | |
| NRX NurExone Biologic | CA$0.83 | 6.4% +CA$5.0m | 33.9% | PB37x | |
| MDNA Medicenna Therapeutics | CA$1.10 | 5.8% +CA$5.0m | -49.1% | PB6.3x | |
| MSCL Satellos Bioscience | CA$0.59 | 3.5% +CA$3.5m | 9.3% | PB2x |